Mats B. Humble

Oerebro, T, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia.

Th1/Th17-linked transcription factors TBX21 and RORC were associated with clinical response to rituximab in treatment-resistant schizophrenia.

Journal: Brain, behavior, & immunity - health
Published: January 15, 2026

Commentary on: "IUPHAR review - Novel therapeutic targets for schizophrenia treatment: A translational perspective".

Commentary on: "IUPHAR review - Novel therapeutic targets for schizophrenia treatment: A translational perspective".

Journal: Pharmacological research
Published: April 24, 2025

Aquaporin-4 positive extracellular vesicles and cytokines in cerebrospinal fluid in schizophrenia and obsessive-compulsive disorder, and associations with peripheral cytokines.

Aquaporin-4 positive extracellular vesicles and cytokines in cerebrospinal fluid in schizophrenia and obsessive-compulsive disorder, and associations with peripheral cytokines.

Journal: Schizophrenia research
Published: February 19, 2025

Circular reasoning concerning Red flags for predicting rituximab response in OCD.

Circular reasoning concerning Red flags for predicting rituximab response in OCD.

Journal: Molecular psychiatry
Published: October 10, 2024

Immunomodulatory treatment may change functional and structural brain imaging in severe mental disorders.

Immunomodulatory treatment may change functional and structural brain imaging in severe mental disorders.

Journal: Brain, behavior, & immunity - health
Published: May 05, 2024

Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits).

Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits).

Journal: BMC psychiatry
Published: September 22, 2023

Alterations in inflammasome-related immunometabolites in individuals with severe psychiatric disorders.

Alterations in inflammasome-related immunometabolites in individuals with severe psychiatric disorders.

Journal: BMC psychiatry
Published: October 06, 2022

Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients.

Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients.

Journal: Journal of psychiatric research
Published: August 09, 2022

Apathy as a Predictor for Conversion From Mild Cognitive Impairment to Dementia: A Systematic Review and Meta-Analysis of Longitudinal Studies.

Apathy as a Predictor for Conversion From Mild Cognitive Impairment to Dementia: A Systematic Review and Meta-Analysis of Longitudinal Studies.

Journal: Journal of geriatric psychiatry and neurology
Published: April 21, 2022

Inflammasome activation in psychosis - Consequence of peripheral dyslipidaemia or reflection of an inflammatory pathogenesis?

Inflammasome activation in psychosis - Consequence of peripheral dyslipidaemia or reflection of an inflammatory pathogenesis?

Journal: Brain, behavior, and immunity
Published: January 14, 2022

The Relationship Between Generalised Joint Hypermobility and Autism Spectrum Disorder in Adults: A Large, Cross-Sectional, Case Control Comparison.

The Relationship Between Generalised Joint Hypermobility and Autism Spectrum Disorder in Adults: A Large, Cross-Sectional, Case Control Comparison.

Journal: Frontiers in psychiatry
Published: October 27, 2021

Joint Hypermobility in Paediatric Acute-Onset Neuropsychiatric Syndrome-A Preliminary Case-Control Study.

Joint Hypermobility in Paediatric Acute-Onset Neuropsychiatric Syndrome-A Preliminary Case-Control Study.

Journal: Frontiers in psychiatry
Published: October 18, 2021
Showing 1-12 of 37

Last Updated: 09/26/2026